Genprex GNPX
NASDAQ GNPX
$2.29 +0.20 (+9.57%)
At close: Nov 11, 2026 · 4:00 PM EST

Genprex (GNPX) EPS (Basic) (2016 - 2026)

Updated

Genprex (GNPX) reported EPS (Basic) of -$14.12 for Q1 2026, compared with -$5.71 a year earlier.

Analysis

Genprex (GNPX) EPS (Basic) (2016 - 2026) Analysis & Trends

Over the twelve months ended Mar 31, 2026, Genprex's EPS (Basic) came in at -$55.16; for FY2024, it came in at -$117.46.

  • By year, EPS (Basic) came in at -$496.39 in FY2023, -$10.89 in FY2022, -$9.65 in FY2021 and -$11.11 in FY2020.
  • The Q1 2026 figure ranks as the lowest quarterly EPS (Basic) since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 7.23
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.09
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 2.38
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.05
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 2.01
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 7.14
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.96
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 0.57
10 Genprex 988,908.54 -41.15 Mn -423,306.00 -9.40
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -9.40
Mar 31, 2026 -14.12
Dec 31, 2025 -109.65
Sep 30, 2025 -109.91
Jun 30, 2025 -3.73
Mar 31, 2025 -5.71
Dec 31, 2024 -23.78
Sep 30, 2024 -27.13
Jun 30, 2024 -66.10
Mar 31, 2024 -84.91
Dec 31, 2023 -2.26
Sep 30, 2023 -2.95
Jun 30, 2023 -3.38
Mar 31, 2023 -4.09
Dec 31, 2022 -2.99
Sep 30, 2022 -2.82
Jun 30, 2022 -2.65
Mar 31, 2022 -2.44
Dec 31, 2021 -3.15
Sep 30, 2021 -1.59
API Access

Genprex EPS (Basic) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-basic&ticker=GNPX&period=max&api_key=YOUR_API_KEY